uniQure N.V.

QURE · Nasdaq · SIC 2834: Pharmaceutical Preparations
268
SEC Filings

Business Summary

. Overview We are a leader in the field of gene therapy, seeking to deliver to patients suffering from rare and other devastating diseases single treatments with potentially curative results. We are advancing a focused pipeline of innovative gene therapies, including our clinical candidates for the treatment of Huntingtons disease, refractory mesial temporal lobe epilepsy (MTLE), Fabry disease, and amyotrophic lateral sclerosis caused by mutations in superoxide dismutase 1 (SOD1-ALS). Recent Pro...

Next Earnings

Q2 FY2026 — expected 2026-09-26

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionQUREdiscussed_in_filing Cloud Computing
topic_mentionQUREdiscussed_in_filing Cybersecurity
topic_mentionQUREdiscussed_in_filing Trusted Computing
topic_mentionQUREdiscussed_in_filing Blockchain & Crypto
topic_mentionQUREdiscussed_in_filing Regulation
topic_mentionQUREdiscussed_in_filing Healthcare & Bio
topic_mentionQUREdiscussed_in_filing Sovereign & Government
topic_mentionQUREdiscussed_in_filing Cloud Computing
topic_mentionQUREdiscussed_in_filing Cybersecurity
topic_mentionQUREdiscussed_in_filing Trusted Computing
topic_mentionQUREdiscussed_in_filing Blockchain & Crypto
topic_mentionQUREdiscussed_in_filing Regulation
topic_mentionQUREdiscussed_in_filing Healthcare & Bio
topic_mentionQUREdiscussed_in_filing Sovereign & Government
topic_mentionQUREdiscussed_in_filing Cloud Computing
topic_mentionQUREdiscussed_in_filing Cybersecurity
topic_mentionQUREdiscussed_in_filing Trusted Computing
topic_mentionQUREdiscussed_in_filing Blockchain & Crypto
topic_mentionQUREdiscussed_in_filing Regulation
topic_mentionQUREdiscussed_in_filing Healthcare & Bio

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-022025-12-310001104659-26-021898EDGAR107K words
2025-02-272024-12-310001558370-25-001699EDGAR—
2024-02-282023-12-310001558370-24-001915EDGAR—
2023-02-272022-12-310001558370-23-002110EDGAR—
2022-02-252021-12-310001558370-22-002050EDGAR—
2021-03-012020-12-310001558370-21-002186EDGAR—
2020-03-022019-12-310001558370-20-001883EDGAR—
2019-02-282018-12-310001558370-19-001305EDGAR—
2018-03-142017-12-310001558370-18-002042EDGAR—
2017-03-152016-12-310001047469-17-001589EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-102025-09-300001104659-25-108813EDGAR62K words
2025-07-292025-06-300001558370-25-009694EDGAR—
2025-05-092025-03-310001558370-25-007068EDGAR—
2024-11-052024-09-300001558370-24-014346EDGAR—
2024-08-012024-06-300001558370-24-010528EDGAR—
2024-05-072024-03-310001558370-24-006914EDGAR—
2023-11-072023-09-300001558370-23-017867EDGAR—
2023-08-012023-06-300001558370-23-012633EDGAR—
2023-05-092023-03-310001558370-23-008658EDGAR—
2022-11-022022-09-300001558370-22-015906EDGAR—
2022-08-082022-06-300001558370-22-012523EDGAR—
2022-05-022022-03-310001558370-22-006570EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-020001104659-26-021890EDGAR4K words
2026-01-130001104659-26-003075EDGAR—
2026-01-090001104659-26-002317EDGAR—
2025-12-040001104659-25-118292EDGAR—
2025-11-100001104659-25-108802EDGAR—
2025-11-030001104659-25-105223EDGAR—
2025-09-290001104659-25-094011EDGAR—
2025-09-240001104659-25-092750EDGAR—
2025-09-240001104659-25-092740EDGAR—
2025-07-290001104659-25-071441EDGAR—

268 total filings indexed. 236 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001590560
TickerQURE
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: fc4e59409fe5b795693dcee102fca493bd3050bdd08d442e96cbad1769d1370e
parent: 07c5f7702c28c6bdfe7503299c1e06af50823b427d6bb95646141e95e6d0aa00
content hash: 8ae91d6f44e84a82d5bbd84882ca4e18c1acafd1debaed3925dd673fc7fccfbe
signed: 2026-04-13T04:47:06.327Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf